NEW YORK — Consumer microbiome testing firm Ombre, formerly called Thryve, said on Monday that it has raised $3 million in seed funding.
PivotNorth Capital led the financing round with participation from Trail Mix Ventures, Shanda Group, Unilever Ventures, Social Starts' fund Joyance Partners, and Unpopular Ventures. Ombre said it has raised $9.5 million to date including the seed funding.
The company, which changed its name in connection with the seed funding, markets a service that analyzes an individual's gut microbiome using an at-home collected fecal sample to provide a gut health report, as well as personalized food and probiotic supplement recommendations.
The San Francisco-based company said it aims to improve its products, supply chain, and services including home tests, gut health reports, probiotic formulations, and a mobile app.
"Ombre has excellent unit economics with the ability to upsell test takers to probiotic subscribers," PivotNorth founder Tim Connors said in a statement. "We see a significant upside as the business is relaunched with a new trademark, supply chain improvements, and demonstrated consumer demand for probiotic products."